Patents by Inventor Jonathan Stephens

Jonathan Stephens has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12329727
    Abstract: Described herein are methods for treating COVID-19 or preventing COVID-19 in a subject exposed to SARS-CoV-2 by administering to the subject a therapeutically effective amount of salmeterol or the pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: June 17, 2025
    Assignee: The Medical College of Wisconsin, Inc.
    Inventors: Jonathan Stephen Marchant, Tom Paul Aufderheide
  • Patent number: 12178813
    Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
    Type: Grant
    Filed: December 31, 2020
    Date of Patent: December 31, 2024
    Assignee: Nxera Pharma UK Limited
    Inventors: John Andrew Christopher, Miles Stuart Congreve, Sarah Joanne Bucknell, Francesca Deflorian, Mark Pickworth, Jonathan Stephen Mason
  • Patent number: 12054472
    Abstract: According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1-A2b or, particularly, the A2a receptor. A process for the preparation of the compound, pharmaceutical compositions comprising the compound, and methods of treatment comprising administration of an effective amount of the compound are also disclosed.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: August 6, 2024
    Assignee: Nxera Pharma UK Limited
    Inventors: Miles Stuart Congreve, Stephen Philippe Andrews, Jonathan Stephen Mason, Christine Mary Richardson, Giles Albert Brown
  • Publication number: 20240217930
    Abstract: The invention described herein relates to compounds of Formula (1b): or a salt thereof, wherein R1, R1a, R2, R3 and R5 are defined herein, and their use in the treatment of SARS-CoV-2 and related viruses and disorders associated with SARS-CoV-2.
    Type: Application
    Filed: April 1, 2022
    Publication date: July 4, 2024
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Miles Stuart CONGREVE, John Andrew CHRISTOPHER, Mark PICKWORTH, Chris DE GRAAF, Alicia Perez HIGUERUELO, Jonathan Stephen MASON
  • Publication number: 20240083845
    Abstract: The disclosures herein relate to compounds of Formula (1?): or a salt thereof, wherein A, Q, X, Z, L, R2, R3 and R9 are defined herein, and their use in the treatment of SARS-CoV-2 and related viruses and disorders associated with SARS-CoV-2: Mpro.
    Type: Application
    Filed: December 20, 2021
    Publication date: March 14, 2024
    Applicant: HEPTARES THERAPEUTICS LIMITED
    Inventors: Miles Stuart CONGREVE, John Andrew CHRISTOPHER, Mark PICKWORTH, Chris DE GRAAF, Alicia Perez HIGUERUELO, Jonathan Stephen MASON, Santosh S. KULKARNI
  • Patent number: 11921777
    Abstract: Digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. The plurality of digital images each capture the object for inclusion as part of generating digital content, e.g., a webpage, a thumbnail to represent a digital video, and so on. In one example, digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. As a result, the service provider system may select a digital image of an object from a plurality of digital images of the object that has an increased likelihood of achieving a desired outcome and may address the multitude of different ways in which an object may be presented to a user.
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: March 5, 2024
    Assignee: Adobe Inc.
    Inventors: Ajay Jain, Sanjeev Tagra, Sachin Soni, Ryan Timothy Rozich, Nikaash Puri, Jonathan Stephen Roeder
  • Publication number: 20230376676
    Abstract: Provided are improved machine learning-based text editing models. Specifically, example implementations include a flexible semi-auto-regressive text-editing approach for generation, designed to derive the maximum benefit from non-auto-regressive text-editing and autoregressive decoding. In contrast to conventional sequence-to-sequence (seq2seq) models, the proposed approach is fast at inference time, while being capable of modeling flexible input-output transformations.
    Type: Application
    Filed: May 23, 2022
    Publication date: November 23, 2023
    Inventors: Jonathan Stephen Mallinson, Aliaksei Severyn, Eric Emil Malmi, Jakub Adamek
  • Publication number: 20230271964
    Abstract: Described herein are triazalone compounds of Formula (I) and pharmaceutically acceptable salts thereof. Methods of making and using compounds of Formula (I) are also described. Compounds of Formula (I) and pharmaceutically acceptable salts thereof can be useful as adenosine receptor antagonists, for example in the treatment of diseases or conditions mediated by the adenosine receptor, such as cancer, movement disorders, or attention disorders.
    Type: Application
    Filed: March 25, 2021
    Publication date: August 31, 2023
    Inventors: Giles Albert Brown, Christine Mary Richardson, Miles Stuart Congreve, Rebecca Paul, Stephen Philippe Andrews, Jonathan Stephen Mason
  • Publication number: 20230149327
    Abstract: Described herein are methods for treating COVID-19 or preventing COVID-19 in a subject exposed to SARS-CoV-2 by administering to the subject a therapeutically effective amount of salmeterol or the pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 21, 2021
    Publication date: May 18, 2023
    Inventors: Jonathan Stephen Marchant, Tom Paul Aufderheide
  • Publication number: 20230146483
    Abstract: Described herein are triazalone compounds of Formula (I): and pharmaceutically acceptable salts thereof. Methods of making and using compounds of Formula (I) are also described. Compounds of Formula (I) and pharmaceutically acceptable salts thereof can be useful as adenosine receptor antagonists, for example in the treatment of diseases or conditions mediated by the adenosine receptor, such as cancer, movement disorders, or attention disorders.
    Type: Application
    Filed: March 25, 2021
    Publication date: May 11, 2023
    Inventors: Giles Albert Brown, Miles Stuart Congreve, Christine Mary Richardson, Rebecca Paul, Stephen Philippe Andrews, Jonathan Stephen Mason, Francesca Deflorian, Nigel Alan Swain
  • Publication number: 20230146796
    Abstract: Described herein are triazalone compounds of Formula (I): and pharmaceutically acceptable salts thereof. Methods of making and using compounds of Formula (I) are also described. Compounds of Formula (I) and pharmaceutically acceptable salts thereof can be useful as adenosine receptor antagonists, for example in the treatment of diseases or conditions mediated by the adenosine receptor, such as cancer, movement disorders, or attention disorders.
    Type: Application
    Filed: March 25, 2021
    Publication date: May 11, 2023
    Applicant: ASTRAZENECA AB
    Inventors: Giles Albert Brown, Miles Stuart Congreve, Stephen Philippe Andrews, Jonathan Stephen Mason, Francesca Deflorian, Nigel Alan Swain
  • Publication number: 20230021177
    Abstract: According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1-A2b or, particularly, the A2a receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy1 or HetA; Cy1 represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy1 group is optionally substituted by one or more R4a substituents; HetA represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more hetermatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy2 or HetB; Cy2 represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, whic
    Type: Application
    Filed: April 23, 2021
    Publication date: January 19, 2023
    Inventors: Miles Stuart Congreve, Stephen Philippe Andrews, Jonathan Stephen Mason, Christine Mary Richardson, Giles Albert Brown
  • Publication number: 20220253478
    Abstract: Digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. The plurality of digital images each capture the object for inclusion as part of generating digital content, e.g., a webpage, a thumbnail to represent a digital video, and so on. In one example, digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. As a result, the service provider system may select a digital image of an object from a plurality of digital images of the object that has an increased likelihood of achieving a desired outcome and may address the multitude of different ways in which an object may be presented to a user.
    Type: Application
    Filed: April 26, 2022
    Publication date: August 11, 2022
    Applicant: Adobe Inc.
    Inventors: Ajay Jain, Sanjeev Tagra, Sachin Soni, Ryan Timothy Rozich, Nikaash Puri, Jonathan Stephen Roeder
  • Patent number: 11397764
    Abstract: Digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. The plurality of digital images each capture the object for inclusion as part of generating digital content, e.g., a webpage, a thumbnail to represent a digital video, and so on. In one example, digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. As a result, the service provider system may select a digital image of an object from a plurality of digital images of the object that has an increased likelihood of achieving a desired outcome and may address the multitude of different ways in which an object may be presented to a user.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: July 26, 2022
    Assignee: Adobe Inc.
    Inventors: Ajay Jain, Sanjeev Tagra, Sachin Soni, Ryan Timothy Rozich, Nikaash Puri, Jonathan Stephen Roeder
  • Publication number: 20220114624
    Abstract: Digital content text processing techniques are described. In one example, a text corpus is extracted from digital content and text corpus keywords are identified that are included in the text corpus. A plurality of clusters is formed based on the text corpus keywords. Cluster scores are generated for reviews that define a probability the review belongs to a respective cluster, e.g., based on review keywords extracted from the reviews. Sentiment values and sentiment weights are also generated. The sentiment values describe a sentiment that each of the reviews exhibits towards a respective cluster, e.g., a type of sentiment such as positive, neutral, or negative. The sentiment weights describe an amount of weight to be applied for each sentiment with respect to that cluster. The service provider system then generates ranking scores based on the cluster scores and the sentiment scores which are used to control output of the reviews.
    Type: Application
    Filed: October 9, 2020
    Publication date: April 14, 2022
    Applicant: Adobe Inc.
    Inventors: Ajay Jain, Shagun Kush, Sanjeev Tagra, Sachin Soni, Ryan Timothy Rozich, Jonathan Stephen Roeder
  • Publication number: 20210232621
    Abstract: Digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. The plurality of digital images each capture the object for inclusion as part of generating digital content, e.g., a webpage, a thumbnail to represent a digital video, and so on. In one example, digital image selection techniques are described that employ machine learning to select a digital image of an object from a plurality of digital images of the object. As a result, the service provider system may select a digital image of an object from a plurality of digital images of the object that has an increased likelihood of achieving a desired outcome and may address the multitude of different ways in which an object may be presented to a user.
    Type: Application
    Filed: January 28, 2020
    Publication date: July 29, 2021
    Applicant: Adobe Inc.
    Inventors: Ajay Jain, Sanjeev Tagra, Sachin Soni, Ryan Timothy Rozich, Nikaash Puri, Jonathan Stephen Roeder
  • Publication number: 20210213011
    Abstract: The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function.
    Type: Application
    Filed: December 31, 2020
    Publication date: July 15, 2021
    Inventors: John Andrew Christopher, Miles Stuart Congreve, Sarah Joanne Bucknell, Francesca Deflorian, Mark Pickworth, Jonathan Stephen Mason
  • Publication number: 20210204614
    Abstract: The present disclosure relates to the field of smoking tobacco. In particular, the present disclosure relates to smoking substitute systems and particularly, although not exclusively, to a heat-not-burn (HNB) smoking substitute system. Further in particular, the present disclosure relates to a smoking substitute system having at least two different modes of operation. The present disclosure also relates to an improved housing design. The present disclosure further relates to a smoking substitute device with an improved housing design. The present disclosure yet further relates to smoking substitute systems having at least two independent display elements.
    Type: Application
    Filed: March 24, 2021
    Publication date: July 8, 2021
    Inventors: Kate Ferrie, Edward Ross SHENTON, Christopher LORD, Med BENYUEZZAR, Jonathan Stephen MARCHBANK, Peter LOMAS, Tom Stephen SUDLOW
  • Patent number: 10991029
    Abstract: Background content suggestion for combination with identified items is described. Initially, a system receives digital visual content depicting an item, e.g., a product for purchase. The system identifies various content items that are available for suggesting as replacement backgrounds for the item and then determines a compatibility of these identified content items with the item depicted in the received digital visual content. In particular, the system determines compatibility based on both a scene compatibility and a color compatibility of the identified content items with the depicted item. Based on a combination of the scene and color compatibility, the system surfaces at least one of the identified content items (e.g., a highest scoring content item) as a suggested replacement background for the depicted item.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: April 27, 2021
    Assignee: Adobe Inc.
    Inventors: Ajay Jain, Jonathan Stephen Roeder, Ryan Timothy Rozich, Sachin Soni, Sanjeev Tagra
  • Patent number: 10988455
    Abstract: According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1-A2b or, particularly, the A2a receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy1 or HetA; Cy1 represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy1 group is optionally substituted by one or more R4a substituents; HetA represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy2 or HetB; Cy2 represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, whic
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: April 27, 2021
    Assignee: Heptares Therapeutics Limited
    Inventors: Miles Stuart Congreve, Stephen Philippe Andrews, Jonathan Stephen Mason, Christine Mary Richardson, Giles Albert Brown